Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes.

J Clin Med · 2023 · PMC10532177 · PMID 37762991

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep -value = 0.08so close (0.05 < p ≤ 0.1)

48.5% of patients in the SWITCH group, although this difference did not reach statistical significance ( p -value = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.